Credits Available: 4.50 AMA PRA Category 1 Credit™ & 4.50 MOC points

Description: Immunotherapy, which has demonstrated benefits in advanced and metastatic settings, is moving into early non-small cell lung cancer treatment, expanding options for patients with resected or resectable early-stage non-small cell lung cancer. This rapid evolution of the early NSCLC treatment landscape, while exciting, has created clinical challenges as health care providers struggle with translating these clinical trial results into real-world clinical practices in the adjuvant and neoadjuvant settings. This educational initiative establishes impactful small group interactions among oncology care providers that will, through a variety of collaborative educational experiences, help them optimize the care of their patients with early-stage NSCLC.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Assistant
Target Specialties: Oncology

Jasmine Patel

Memorial Sloan Ketting Cancer Center

I am a clinical oncology pharmacy specialist in Thoracic Oncology at Memorial Sloan Kettering Cancer Center. I previously trained and worked at Boston Medical Center where my focus was primarily ambulatory oral targeted therapy/chemotherapy. I have done previous grant work with metastatic breast cancer, prostate cancer and disparities in care, and targeted therapy with non-small cell lung cancer. My areas of interest include education, targeted therapies, and disparities in cancer care.